SIG — Sigma Healthcare Cashflow Statement
0.000.00%
- AU$4.74bn
- AU$4.86bn
- AU$4.93bn
- 52
- 34
- 100
- 65
Annual cashflow statement for Sigma Healthcare, fiscal year end - January 31st, AUD millions except per share, conversion factor applied.
C2021 January 31st | 2022 January 31st | C2023 January 31st | 2024 January 31st | 2025 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.361 | 0.221 | 0.597 | 1.69 | 8.04 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -13.1 | -46.3 | 136 | 42 | -316 |
Capital Expenditures | -51.4 | -14.2 | -29.4 | -4.72 | -7.91 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 176 | -2.39 | 0.795 | 10.5 | 6.31 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 124 | -16.6 | -28.6 | 5.73 | -1.6 |
Financing Cash Flow Items | -1.59 | 0 | -0.98 | -0.809 | -1.35 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -266 | 129 | -110 | 296 | -24.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -154 | 66 | -2.8 | 344 | -342 |